Note: Single-source report; awaiting corroboration.
The World Health Organization (WHO) has released a report assessing progress on the Global Health Sector Strategies for HIV, viral hepatitis, and sexually transmitted infections (STIs) for 2022 to 2030. The report was launched during the 26th International AIDS Conference and ahead of World Hepatitis Day, highlighting significant achievements and ongoing challenges in combating these epidemics.
By the end of 2025, approximately 32 million people living with HIV were receiving treatment. Since 2010, new HIV infections have fallen by 42% and AIDS-related deaths by 57%. However, 9 million people still lack access to life-saving HIV treatment, and new infections are rising in certain regions, particularly among key populations such as men who have sex with men, sex workers, people who inject drugs, transgender individuals, and people in prisons.
Progress was also made in the viral hepatitis response. Since 2015, annual hepatitis B infections decreased by 32%, and hepatitis C-related deaths fell by 12% globally. Despite these improvements, viral hepatitis remains one of the world’s deadliest infectious diseases, causing an estimated 1.3 million deaths in 2024, with mortality rates continuing to rise.
The response to STIs showed mixed results. While national policies were strengthened, syphilis screening and treatment in pregnancy improved, and HPV vaccination coverage increased modestly, STI rates rose in several countries and communities. Additionally, antibiotic resistance in gonorrhoea remains a growing concern.
The report identified challenges such as disruptions from reduced international donor funding in 2025, which affected HIV prevention programs like pre-exposure prophylaxis (PrEP). Despite some governments stepping in to maintain services, preliminary data indicated declines in PrEP use in several countries and communities.
For viral hepatitis, deaths related to hepatitis B increased by 17% since 2015. Diagnosis and treatment coverage remain low, especially for hepatitis B, even though highly effective medicines are available to prevent millions of deaths. WHO emphasized the need to build integrated and resilient health systems to overcome inequalities and sustain progress.